Your browser doesn't support javascript.
loading
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE).
Ambrosy, Andrew P; Malik, Umar I; Thomas, Rachel C; Parikh, Rishi V; Tan, Thida C; Goh, Choon H; Selby, Van N; Solomon, Matthew D; Avula, Harshith R; Fitzpatrick, Jesse K; Skarbinski, Jacek; Philip, Sephy; Granowitz, Craig; Bhatt, Deepak L; Go, Alan S.
Afiliação
  • Ambrosy AP; Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA; Division of Research, Kaiser Permanente Northern California, Oakland, CA. Electronic address: andrew.p.ambrosy@kp.org.
  • Malik UI; Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA.
  • Thomas RC; Division of Research, Kaiser Permanente Northern California, Oakland, CA.
  • Parikh RV; Division of Research, Kaiser Permanente Northern California, Oakland, CA.
  • Tan TC; Division of Research, Kaiser Permanente Northern California, Oakland, CA.
  • Goh CH; Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA.
  • Selby VN; Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA.
  • Solomon MD; Division of Research, Kaiser Permanente Northern California, Oakland, CA; Department of Cardiology, Kaiser Permanente Oakland Medical Center, Oakland, CA.
  • Avula HR; Department of Cardiology, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, CA.
  • Fitzpatrick JK; Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA.
  • Skarbinski J; Division of Research, Kaiser Permanente Northern California, Oakland, CA; Department of Infectious Disease, Kaiser Permanente Oakland Medical Center, Oakland, CA.
  • Philip S; Amarin Pharma, Inc., Bridgewater, NJ.
  • Granowitz C; Amarin Pharma, Inc., Bridgewater, NJ.
  • Bhatt DL; Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA.
  • Go AS; Division of Research, Kaiser Permanente Northern California, Oakland, CA; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA; Departments of Medicine (Nephrology), Epidemiology, and Biostatistics, University of California, San Francisco, San Fra
Am Heart J ; 235: 54-64, 2021 05.
Article em En | MEDLINE | ID: mdl-33516752
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Doenças Cardiovasculares / Ácido Eicosapentaenoico / Aterosclerose / COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Doenças Cardiovasculares / Ácido Eicosapentaenoico / Aterosclerose / COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Ano de publicação: 2021 Tipo de documento: Article